These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 31227053)

  • 1. PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy.
    Wester HJ; Schottelius M
    Semin Nucl Med; 2019 Jul; 49(4):302-312. PubMed ID: 31227053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
    Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
    J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer.
    Pillai MRA; Nanabala R; Joy A; Sasikumar A; Russ Knapp FF
    Nucl Med Biol; 2016 Nov; 43(11):692-720. PubMed ID: 27589333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer.
    Afshar-Oromieh A; Babich JW; Kratochwil C; Giesel FL; Eisenhut M; Kopka K; Haberkorn U
    J Nucl Med; 2016 Oct; 57(Suppl 3):79S-89S. PubMed ID: 27694178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer.
    Schottelius M; Wurzer A; Wissmiller K; Beck R; Koch M; Gorpas D; Notni J; Buckle T; van Oosterom MN; Steiger K; Ntziachristos V; Schwaiger M; van Leeuwen FWB; Wester HJ
    J Nucl Med; 2019 Jan; 60(1):71-78. PubMed ID: 30237214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer.
    Kratochwil C; Afshar-Oromieh A; Kopka K; Haberkorn U; Giesel FL
    Semin Nucl Med; 2016 Sep; 46(5):405-18. PubMed ID: 27553466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy.
    Eiber M; Fendler WP; Rowe SP; Calais J; Hofman MS; Maurer T; Schwarzenboeck SM; Kratowchil C; Herrmann K; Giesel FL
    J Nucl Med; 2017 Sep; 58(Suppl 2):67S-76S. PubMed ID: 28864615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and Biological Evaluation of [
    Xiao D; Duan X; Gan Q; Zhang X; Zhang J
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33256058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors.
    Kelly J; Amor-Coarasa A; Ponnala S; Nikolopoulou A; Williams C; Schlyer D; Zhao Y; Kim D; Babich JW
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1841-1851. PubMed ID: 29623376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group.
    Miyahira AK; Pienta KJ; Morris MJ; Bander NH; Baum RP; Fendler WP; Goeckeler W; Gorin MA; Hennekes H; Pomper MG; Sartor O; Tagawa ST; Williams S; Soule HR
    Prostate; 2018 Aug; 78(11):775-789. PubMed ID: 29717499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PSMA-targeted radioligand therapy in prostate cancer].
    Heck MM; Retz M; Tauber R; Knorr K; Kratochwil C; Eiber M
    Urologe A; 2017 Jan; 56(1):32-39. PubMed ID: 27885457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
    Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S
    Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pre-clinical evaluation of a new class of high-affinity
    Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSMA-Targeting Imaging and Theranostic Agents-Current Status and Future Perspective.
    Debnath S; Zhou N; McLaughlin M; Rice S; Pillai AK; Hao G; Sun X
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window.
    Kelly JM; Amor-Coarasa A; Ponnala S; Nikolopoulou A; Williams C; DiMagno SG; Babich JW
    J Nucl Med; 2019 May; 60(5):656-663. PubMed ID: 30552199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.
    Ceci F; Castellucci P; Fanti S
    Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):7-18. PubMed ID: 29521482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
    Hillier SM; Maresca KP; Lu G; Merkin RD; Marquis JC; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    J Nucl Med; 2013 Aug; 54(8):1369-76. PubMed ID: 23733925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of
    Pham TT; Hungnes IN; Rivas C; Cleaver J; Firth G; Blower PJ; Sosabowski J; Cook GJR; Livieratos L; Young JD; Pringle PG; Ma MT
    J Nucl Med; 2024 Jul; 65(7):1087-1094. PubMed ID: 38844360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy.
    Verburg FA; Luster M
    Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1611-1613. PubMed ID: 28677048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.